Aortic valve replacement for severe aortic stenosis or aortic insufficiency with advanced left ventricular dysfunction

S. Chris Malaisrie*, Patrick M. McCarthy

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Aortic valve replacement (AVR) is the standard treatment for patient with severe, symptomatic aortic stenosis. Transcatheter aortic valve implantation (TAVI) is the new standard of therapy for those patients that are unsuitable for open heart surgery. In patients considered to be high risk secondary to severe comorbidities, TAVI may be an acceptable alternative to AVR. Future applications of transcatheter heart valves include intermediate-risk patients and failed bioprosthetic valves.

Original languageEnglish (US)
Title of host publicationSurgical Treatment for Advanced Heart Failure
PublisherSpringer New York
Pages49-61
Number of pages13
ISBN (Electronic)9781461469193
ISBN (Print)146146918X, 9781461469186
DOIs
StatePublished - Jul 1 2013

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Aortic valve replacement for severe aortic stenosis or aortic insufficiency with advanced left ventricular dysfunction'. Together they form a unique fingerprint.

Cite this